Search
for
Sort by
Research 31–60 of 1000+
- EVENTOS ADVERSOS E DEMAIS INCIDENTES NO CUIDADO ESTÉTICO REALIZADO PELO BIOMÉDICO
- Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study
- Deoxycholic acid in the submental fat reduction: A review of properties, adverse effects, and complications
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Cutaneous toxicities of new treatments for melanoma
- Dermatologic Care of the Transplant Patient
- Cemiplimab-Induced Alopecia Areata
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Topical Eflornithine
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- The “in’s and outs” of laser hair removal: a mini review
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- Cutaneous manifestations associated with immune checkpoint inhibitors
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Proinflammatory Event of Ozonized Olive Oil in Mice
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- 61349 The Development of Vitiligo After Cessation of Finasteride: Is this Part of Post-Finasteride Syndrome or an Adverse Event of Finasteride?
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections